Skip to main content
Radiology Case Reports logoLink to Radiology Case Reports
. 2020 Oct 17;15(12):2663–2667. doi: 10.1016/j.radcr.2020.10.019

Mycotic pseudoaneurysm of the hepatic artery as a complication of radiofrequency ablation of hepatic metastases

Helen Hoi Lam Ng a, Lynn Ling b, Peter Lodge c, Christopher Hammond d, Tze Min Wah e,
PMCID: PMC7575651  PMID: 33101562

Abstract

Image-guided radiofrequency ablation is frequently used to treat small hepatocellular carcinoma and metastases. Complications associated with this thermal-based technology for liver cancers arise via direct mechanical injury by the electrodes or collateral thermal damage to surrounding structures. This case report describes an unusual presentation of hepatic arterial mycotic pseudoaneurysm as melaena after percutaneous image-guided radiofrequency ablation for liver metastases in a patient with a previous surgical history of hepaticojejunostomy for cholangiocarcinoma. The patient had a lifesaving procedure to treat the hepatic pseudoaneurysm with transarterial glue embolization.

Keywords: Radiofrequency ablation, RFA, Liver metastasis, Hepatic artery, Pseudoaneurysm, Complication

Case Report

This case report has followed the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Introduction

Radiofrequency ablation (RFA) is an established image-guided thermal ablation technique to treat small primary and secondary liver cancers when a patient is not suitable for surgical resection, especially if the tumors are inoperable due to their number and distribution [1]. RFA is an effective treatment for small hepatocellular carcinomas <2 cm with similar overall survival rates when compared with surgical resection [2]. Vascular complications of image-guided RFA can be due to direct mechanical injury caused by the electrode or collateral thermal damage during ablation. Arterial hemorrhage, pseudoaneurysm, arteriovenous fistula, hepatic and portal vein thrombosis and hepatic venous infarction have been previously reported [3].

Hemobilia, (bleeding into the biliary tree), is an unusual and frequently occult cause of upper gastrointestinal bleeding. It is usually iatrogenic or traumatic in origin. Hepatic artery aneurysms account for nearly 10% of all cases of hemobilia and are usually due to atherosclerosis, trauma or biliary inflammation in the setting of cholestasis [4]. This case report describes an unusual presentation of hemobilia presenting as melaena, secondary to a mycotic hepatic artery pseudoaneurysm as a result of a complication from image-guided RFA performed on a patient with previous biliary surgery.

Case Presentation

A 53-year-old female with a history of papillary intraductal cholangiocarcinoma had previously undergone right hemihepatectomy with biliary reconstruction using a Roux-en-Y hepaticojejunostomy. A follow-up computed tomography (CT) scan at 5 years demonstrated 2 small slow-growing liver lesions, measuring at 25 mm and 10 mm, respectively, consistent with metastases (Fig. 1a and b). She was subsequently referred for image-guided RFA.

Fig. 1.

Fig 1

Contrast enhanced CT liver demonstrating 2 lesions in (a) central location (vertical white arrow) and (b) superficial location (horizontal white arrow) in keeping with recurrent colorectal metastases. The abdominal morphology of the liver is due to an abdominal wall herniation from previous surgery.

The patient underwent image-guided RFA (Fig. 2a and b). The 25mm lesion was treated with a 4 cm LeVeen needle electrode consisting of 3 overlapping ablations with a total treatment time of 20 minutes 30 seconds. The 10 mm lesion was treated with a 3 cm LeVeen needle electrode involving two overlapping ablations with a total treatment time of 10 minutes 59 seconds. There were no immediate complications, and the patient was discharged home the next day.

Fig. 2.

Fig 2

Non contrast-enhanced CT with RFA electrode (white arrow) sited in the central metastasis in the (a) axial and (b) coronal section.

The patient was readmitted 11 days post-RFA with melaena and rectal bleeding. An urgent oesophago-gastro-duodenoscopy revealed gastric fundal varices but without stigmata of recent hemorrhage. Despite this, the initial impression was that the varices were the source of bleeding. The bleeding stopped spontaneously. Later, the patient developed sepsis with rigors, fever, and elevated acute phase proteins (CRP 181 mg/L). Streptococcus viridans and Escherichia coli were isolated in blood cultures. An abdominal CT scan performed at porto-venous (PV) phase showed focal hepatic necrosis with locules of gas at the RFA site, consistent with an abscess formation within the zone of ablation (Fig. 3). She improved steadily after commencement of intravenous antibiotics.

Fig. 3.

Fig 3

Locules of gas (white arrows) shown on the contrast-enhanced CT scan during porto-venous phase 11 days post-RFA, the appearances are suggestive of an abscess formation from infected zone of ablation.

At day-15 post RFA, there was further severe gastrointestinal hemorrhage with melaena and rectal bleeding (hemoglobin level fell to 7.8 g/dL despite 4 units of packed red cell transfusion). The results of a further oesophago-gastro-duodenoscopy were negative. A CT angiogram during the arterial phase demonstrated a new 20 × 16 mm avidly enhancing lesion adjacent to the abscess, consistent with a mycotic pseudoaneurysm (Fig. 4) causing the clinically observed hemobilia leading to gastrointestinal hemorrhage. The patient underwent immediate catheter angiography. The pseudoaneurysm was seen to fill from small branches of the left hepatic artery. These arteries were super-selectively catheterized and successfully embellished with Glubran cyanoacrylate glue (Fig. 5a and b). Subsequent follow-up imaging confirmed no evidence of residual or recurrent disease in the zone of ablation for a period of 8 years. The patient died recently at 8 years postablation from disseminated malignancy.

Fig. 4.

Fig 4

Arterial phase contrast-enhanced CT 2-week post-RFA in axial view, demonstrating focal blush at the postero-inferior aspect of the ablated central lesion which is in keeping with a pseudoaneurysm.

Fig. 5.

Fig 5

(a) Selective hepatic angiography confirming the pseudoaneurysm as shown on CT. (b) successful obliteration pf the pseudoaneurysm after glue embolization.

Discussion

This case report describes a patient who underwent image-guided RFA of liver metastases and subsequently developed a hepatic abscess in the zone of ablation, resulting in formation of a hepatic mycotic pseudoaneurysm. While hepatic pseudoaneurysms post-RFA have been reported [5], [6], [7], [8], none were mycotic. Liver abscesses leading to mycotic hepatic artery pseudoaneurysm have been described in the setting of amoebic abscess [9] and as a result of blunt trauma [10], but not as complication post-RFA. Hepatic pseudoaneurysms are associated with a rupture rate ranging between 44% and 88% [11] and often presents with severe gastrointestinal hemorrhage.

RFA is a minimally invasive technique and is increasingly used in management of hepatic malignancy. Many clinical studies have demonstrated its safety and efficacy [12]. Hepatic RFA is associated with a complication rate of 3.1% [13]. Vascular complications (such as hemobilia [14] and pseudoaneurysms [15]) occur between 0.5% and 1% [16]. Tumor seeding and abscess formation occurs in 0.3%-2% of cases [15], [16], [17], [18].

The mechanism of abscess formation after RFA is not fully understood. The patient described in this case report may have been at a higher risk of abscess formation due to a colonized biliary tract as a result of prior bilio-enteric anastomosis. Such anastomoses have been described as a risk factor for bacterial contamination in the postablation necrotic zone [15], possibly leading to an abscess [19]. RFA thermal injury to a colonized biliary tree may contribute to this risk [12].

Pseudoaneurysms are often from iatrogenic trauma as a result of hepatobiliary or vascular surgery [20]. However, the pathogenesis of mycotic aneurysms has not been clearly described. There are 4 proposed causative mechanisms for infective pseudoaneurysm [21], the commonest cause is as a result of intraoperative infection. For the patient described who had a previous hepaticojejunostomy, the hepatic artery may have been damaged by the thermal effect and the zone of ablation may subsequently have become infected by S. viridans and E. coli from the patient's pre-existing biliary tree colonization.

Prophylactic antibiotic use, while empirically attractive in reducing infective complications [22], does not prevent abscess formations posthepatic RFA [23]. Abscess formation occurs despite antibiotic use in complex patients with a history of bilio-enteric anastomosis or diabetes mellitus [24]. A high index of clinical suspicion is required after image-guided ablation in patients with known enteric anastomosis, due to the risk of bacterial colonization and seeding into the zone of ablation.

There is an overlap between the signs and symptoms of abscess development and transient fever associated with postablation syndrome. With postablation syndrome, pyrexia is reported to be relatively low grade and self-limiting, usually resolving by 2 weeks [15].

The mycotic pseudoaneurysm was initially not detected at Day-11 CT post RFA because the scan was performed during the PV phase. Triple phase CT is a scanning technique that includes noncontrast enhanced, arterial and PV phases. The arterial phase is crucial for assessing the vasculature surrounding the zone of ablation for a prompt diagnosis of pseudoaneurysm, so that timely and life-saving selective catheter embolization may be performed.

Conclusion

Mycotic hepatic artery pseudoaneurysm formation post-RFA is a rare but potentially life-threatening complication. A high index of clinical suspicion and arterial phase CT is required for this diagnosis in patients presenting with sepsis and occult GI bleeding post-RFA, especially those with a pre-existing bilio-enteric anastomosis. This case highlights the importance of both clinical and imaging findings in effectively managing the potential complications of RFA.

Acknowledgments

Ethical Approval

No ethical approval was required as the study was not classified as research under the United Kingdom National Health Service Health Research Authority.

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Consent for publication

Consent for publication was obtained for every individual person's data included in the study.

Footnotes

Acknowledgments: The authors made the following contributions to this study: guarantor of integrity of entire study: T.M. Wah; literature search: H.H.L. Ng, L. Ling, T.M. Wah; case acquisition: T.M. Wah; manuscript preparation and editing: H. Ng, L. Ling, T.M. Wah; and manuscript review: all authors.

Funding: This study was not supported by any funding.

Competing Interests: Tze Min Wah receives Educational Grant from Angiodynamics and Research Grant from Boston Scientific.

References

  • 1.NICE. Interventional procedure overview of radiofrequency ablation for the treatment of liver tumours. National Institute of Clinical Excellence. Interventional Procedures Programme Web site. https://www.nice.org.uk/guidance/ipg2/evidence/overview-of-radiofrequency-ablation-of-liver-tumours-pdf-253960237. Published 2003. Accessed September 16, 2020.
  • 2.Cho YK, Kim JK, Kim WT, Chung JW. Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinoma: a Markov model analysis. Hepatology (Baltimore, Md) 2010;51(4):1284–1290. doi: 10.1002/hep.23466. [DOI] [PubMed] [Google Scholar]
  • 3.Rhim H, Yoon KH, Lee JM, Cho Y, Cho JS, Kim SH. Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications. Radiographics. 2004;24(1):41–52. doi: 10.1148/rg.241025144. [DOI] [PubMed] [Google Scholar]
  • 4.Liu TT, Hou MC, Lin HC, Chang FY, Lee SD. Life-threatening hemobilia caused by hepatic artery pseudoaneurysm: a rare complication of chronic cholangitis. World J Gastroenterol. 2003;9(12):2883–2884. doi: 10.3748/wjg.v9.i12.2883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Tamai F, Furuse J, Maru Y, Yoshino M. Intrahepatic pseudoaneurysm: a complication following radio-frequency ablation therapy for hepatocellular carcinoma. Eur J Radiol. 2002;44(1):40–43. doi: 10.1016/s0720-048x(01)00436-3. [DOI] [PubMed] [Google Scholar]
  • 6.Soggiu F, Marescaux J, Pessaux P. Intrahepatic pseudoaneurysm after radiofrequency ablation of liver metastases. Hepatobiliary Surg Nutrit. 2014;3(4):207–208. doi: 10.3978/j.issn.2304-3881.2014.06.06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Datta RV. Intrahepatic pseudoaneurysm after radiofrequency ablation of liver lesion. Int Surg. 2008;93(6):381–384. [PubMed] [Google Scholar]
  • 8.Ch'ng LS, Tazuddin EEM, Young B, Ali AFM. Spontaneous resolution of asymptomatic hepatic pseudoaneurysm post radiofrequency ablation. BJR Case Rep. 2016;2(2) doi: 10.1259/bjrcr.20150306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Gopanpallikar A, Rathi P, Sawant P, Gupta R, Dhadphale S, Deshmukh HL. Hepatic artery pseudoaneurysm associated with amebic liver abscess presenting as upper GI hemorrhage. Am J Gastroenterol. 1997;92(8):1391–1393. [PubMed] [Google Scholar]
  • 10.Owings JT, Lengle SJ. Combined hepatic abscess and arterial pseudoaneurysms from blunt trauma: a case report and management strategy. J Trauma. 1995;38(4):634–638. doi: 10.1097/00005373-199504000-00030. [DOI] [PubMed] [Google Scholar]
  • 11.Kang M, Bapuraj JR, Khandelwal N, Kochhar R, Kalra N, Verma GR. Liver abscess associated with hepatic artery pseudoaneurysm with arteriovenous fistula: imaging and interventional management. Acta Radiol. 2006;47(2):162–166. doi: 10.1080/02841850500466575. [DOI] [PubMed] [Google Scholar]
  • 12.Rhim H, Lim HK, Kim YS, Choi D, Lee WJ. Radiofrequency ablation of hepatic tumors: lessons learned from 3000 procedures. J Gastroenterol Hepatol. 2008;23(10):1492–1500. doi: 10.1111/j.1440-1746.2008.05550.x. [DOI] [PubMed] [Google Scholar]
  • 13.Kim YS, Rhim H, Lim HK. Imaging after radiofrequency ablation of hepatic tumors. Semin Ultrasound CT MR. 2009;30(2):49–66. doi: 10.1053/j.sult.2008.12.004. [DOI] [PubMed] [Google Scholar]
  • 14.Berry R, Han J, Kardashian AA, LaRusso NF, Tabibian JH. Hemobilia: etiology, diagnosis, and treatment. Liver Res. 2018;2(4):200–208. doi: 10.1016/j.livres.2018.09.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Rhim H, Yoon KH, Lee JM, Cho JS, Kim SH. Major complications after radio-frequency thermal ablation of hepatic tumors: spectrum of imaging findings. Radiographics. 2003;23(1):123–134. doi: 10.1148/rg.231025054. discussion 134-126. [DOI] [PubMed] [Google Scholar]
  • 16.Choi D, Lim HK, Kim MJ. Liver abscess after percutaneous radiofrequency ablation for hepatocellular carcinomas: frequency and risk factors. Am J Roentgenol. 2005;184(6):1860–1867. doi: 10.2214/ajr.184.6.01841860. [DOI] [PubMed] [Google Scholar]
  • 17.Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology. 2003;226(2):441–451. doi: 10.1148/radiol.2262012198. [DOI] [PubMed] [Google Scholar]
  • 18.de Baère T, Risse O, Kuoch V. Adverse events during radiofrequency treatment of 582 hepatic tumors. Am J Roentgenol. 2003;181(3):695–700. doi: 10.2214/ajr.181.3.1810695. [DOI] [PubMed] [Google Scholar]
  • 19.Elias D, Di Pietroantonio D, Gachot B, Menegon P, Hakime A, De Baere T. Liver abscess after radiofrequency ablation of tumors in patients with a biliary tract procedure. Gastroenterologie clinique et biologique. 2006;30(6-7):823–827. doi: 10.1016/s0399-8320(06)73327-9. [DOI] [PubMed] [Google Scholar]
  • 20.Pitton MB, Dappa E, Jungmann F. Visceral artery aneurysms: Incidence, management, and outcome analysis in a tertiary care center over one decade. Eur Radiol. 2015;25(7):2004–2014. doi: 10.1007/s00330-015-3599-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Wilson WR, Bower TC, Creager MA. Vascular graft infections, mycotic aneurysms, and endovascular infections: a scientific statement from the american heart association. Circulation. 2016;134(20):e412–e460. doi: 10.1161/CIR.0000000000000457. [DOI] [PubMed] [Google Scholar]
  • 22.Spies JB, Rosen RJ, Lebowitz AS. Antibiotic prophylaxis in vascular and interventional radiology: a rational approach. Radiology. 1988;166(2):381–387. doi: 10.1148/radiology.166.2.3275979. [DOI] [PubMed] [Google Scholar]
  • 23.Kim W, Clark TW, Baum RA, Soulen MC. Risk factors for liver abscess formation after hepatic chemoembolization. J Vasc Intervent Radiol. 2001;12(8):965–968. doi: 10.1016/s1051-0443(07)61577-2. [DOI] [PubMed] [Google Scholar]
  • 24.Shibata T, Yamamoto Y, Yamamoto N. Cholangitis and liver abscess after percutaneous ablation therapy for liver tumors: incidence and risk factors. J Vasc Intervent Radiol. 2003;14(12):1535–1542. doi: 10.1097/01.rvi.0000099532.29957.4f. [DOI] [PubMed] [Google Scholar]

Articles from Radiology Case Reports are provided here courtesy of Elsevier

RESOURCES